Panchsheel Organics Ltd Stock Price Today (NSE: PANCHSHEEL)
Fundamental Score
Panchsheel Organics Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Panchsheel Organics Ltd share price today is ₹122.75, up +6.19% on NSE/BSE as of 22 June 2026. Panchsheel Organics Ltd (PANCHSHEEL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹180.52 (Cr). The 52-week high for PANCHSHEEL share price is ₹184.00 and the 52-week low is ₹86.10. At a P/E ratio of 14.68x, PANCHSHEEL is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 10.65% and a debt-to-equity ratio of 0.03.
Panchsheel Organics Ltd Share Price Chart — NSE/BSE Historical Performance
Panchsheel Organics Ltd share price chart: 6.51% return over the past month. 52-week high ₹184.00, 52-week low ₹86.10.
Panchsheel Organics Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹122.90 | ₹124.20 | ₹114.05 | ₹122.75 | 9.71K (Cr) | |
| ₹138.90 | ₹138.90 | ₹115.20 | ₹115.60 | 73.69K (Cr) | |
| ₹145.15 | ₹148.95 | ₹142.00 | ₹144.00 | 9.22K (Cr) | |
| ₹149.50 | ₹149.50 | ₹141.30 | ₹144.10 | 5.79K (Cr) | |
| ₹144.25 | ₹148.00 | ₹143.00 | ₹145.15 | 14.71K (Cr) | |
| ₹149.45 | ₹154.40 | ₹142.00 | ₹144.95 | 18.42K (Cr) | |
| ₹151.95 | ₹152.00 | ₹142.95 | ₹146.80 | 29.43K (Cr) | |
| ₹140.95 | ₹152.35 | ₹139.00 | ₹146.20 | 53.48K (Cr) | |
| ₹133.00 | ₹140.00 | ₹132.20 | ₹137.55 | 65.45K (Cr) | |
| ₹129.10 | ₹131.00 | ₹125.95 | ₹130.70 | 8.12K (Cr) |
Panchsheel Organics Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹138.90 | ₹138.90 | ₹114.05 | ₹122.75 | -11.63% | |
| ₹114.00 | ₹154.40 | ₹112.80 | ₹144.00 | +26.32% | |
| ₹94.00 | ₹128.70 | ₹90.00 | ₹115.67 | +23.05% | |
| ₹101.30 | ₹111.00 | ₹86.10 | ₹90.20 | -10.96% | |
| ₹105.05 | ₹122.00 | ₹101.25 | ₹108.55 | +3.33% | |
| ₹133.90 | ₹133.90 | ₹101.00 | ₹105.10 | -21.51% | |
| ₹140.20 | ₹140.20 | ₹123.60 | ₹129.90 | -7.35% | |
| ₹145.00 | ₹145.45 | ₹135.00 | ₹138.15 | -4.72% | |
| ₹139.90 | ₹146.00 | ₹131.00 | ₹140.05 | +0.11% | |
| ₹151.55 | ₹156.70 | ₹134.00 | ₹135.55 | -10.56% | |
| ₹184.00 | ₹184.00 | ₹145.73 | ₹151.05 | -17.91% | |
| ₹154.95 | ₹180.00 | ₹142.00 | ₹179.00 | +15.52% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Falling knife microcap API supplier with negative FCF and declining profits; avoid until a clear turnaround.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Panchsheel Organics' stock has experienced a downward trend, hitting a new 52-week low of The company announced the closure of its trading window in anticipation of the financial results for the quarter and year ending March 31, 2026.
CORE STORY (THE REAL GAME)
Commoditized API supplier. Margins are at the mercy of global pharma pricing and supply chain disruptions. Backward integration into APIs is the long-term game, but Panchsheel is a laggard.
- Stock at 52-week low
- Latest quarter YoY profit declined by -31.13% and sales by -6.84% [cite: brief]
- Negative free cash flow of ₹-16.14 Cr [cite: brief]
- Significant order wins with disclosed ₹ value
- Earnings beat expectations by a wide margin
- Successful backward integration into API manufacturing
- Micro/SME cap - liquidity risk
- Negative free cash flow
- Falling knife price action
No FII/DII presence. Promoter holding stable at 56.12% [cite: brief].
Indian pharma exports are growing, but face pricing pressures and trade uncertainties.
No. Free Cash Flow 5Y: ₹-16.14 Cr [cite: brief]
Near-term outlook is bearish. A turnaround depends on successful backward integration and improved profitability, which are uncertain.
Primary Thesis Risk
Inability to improve profitability and generate positive free cash flow will lead to further stock decline.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Panchsheel Organics Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Panchsheel Organics Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of PANCHSHEEL across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Operating Margins (17.98%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 14.68 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (16.42% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (21.12% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.03)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (53.52x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (56.12%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Profit Decline Concern (-31.13%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-6.84%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Negative Free Cash Flow (₹-16.14 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Panchsheel Organics Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Panchsheel Organics Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Panchsheel Organics LtdPanchsheel Orga...Selected✓ PANCHSHEEL • 531726 | 51.8/100 | ₹122.75₹123 | ₹180.52₹180.52 | 14.68Average 14.7 Average | 10.65%Average 10.65% Average | 13.64%Average 13.64% Average | 0.03Excellent 0.0 Excellent | 21.12%Excellent 21.12% Excellent | 16.42%Excellent 16.42% Excellent | 2.33% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1789.90₹1790 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6533.00₹6533 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4317.90₹4318 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1379.30₹1379 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1274.00₹1274 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2249.80₹2250 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹1078.30₹1078 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2299.00₹2299 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1429.20₹1429 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5239.00₹5239 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Panchsheel Organics Ltd PE Ratio History
Historical price-to-earnings ratio for PANCHSHEEL — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹10.47 | ₹129.90 | 12.4x |
| FY 2024 | ₹10.71 | ₹208.20 | 19.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Panchsheel Organics Ltd Dividend History
Annual cash dividends paid by PANCHSHEEL — dividend yield 2.33%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹3.96 Cr |
| FY 2024 | ₹3.53 Cr |
| FY 2023 | ₹3.53 Cr |
| FY 2022 | ₹0.67 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Panchsheel Organics Ltd Quarterly Performance
Latest quarterly metrics for PANCHSHEEL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-6.84%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-31.13%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
16.42%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
21.12%
Compounded annual net profit growth over 5 years
Panchsheel Organics Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for PANCHSHEEL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Panchsheel Organics Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Panchsheel Organics Ltd (PANCHSHEEL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Panchsheel Organics Ltd
About PANCHSHEEL (Panchsheel Organics Ltd)
Panchsheel Organics Ltd is a dynamic pharmaceutical company dedicated to developing, manufacturing, and distributing high-quality pharmaceutical products. With a strong commitment ...to innovation and excellence, Panchsheel Organics focuses on producing a diverse portfolio of active pharmaceutical ingredients (APIs), advanced intermediates, and finished formulations. These products cater to a wide range of therapeutic areas, ensuring the company contributes significantly to global healthcare needs. Leveraging state-of-the-art manufacturing facilities and adhering to stringent regulatory standards, Panchsheel Organics strives to deliver safe, effective, and affordable medications to patients worldwide. The company’s dedication to research and development allows it to continually expand its product offerings and adapt to evolving market demands. Panchsheel Organics operates on a global scale, engaging in both domestic and international trade. The company’s extensive product line encompasses a variety of specialized categories, including treatments for cardiovascular diseases, mental health disorders, and infectious diseases. Moreover, Panchsheel Organics is committed to advancing treatments in niche areas like hormonal therapies and specialized chemical compounds. Through strategic partnerships and a robust distribution network, the company ensures its products reach healthcare providers and patients across diverse geographical regions. This global presence allows Panchsheel Organics to contribute to improved health outcomes and address unmet medical needs around the world. Driven by a vision of becoming a leading pharmaceutical solutions provider, Panchsheel Organics invests heavily in research and development, regulatory compliance, and quality control. The company’s commitment to ethical business practices and environmental sustainability underscores its responsibility to stakeholders and the communities it serves. By focusing on innovation, quality, and accessibility, Panchsheel Organics aims to improve the lives of individuals by providing reliable and affordable pharmaceutical solutions. The company continuously seeks opportunities to expand its product portfolio and market presence, solidifying its position as a trusted partner in the healthcare industry.
Company Details
Key Leadership
Corporate Events
Latest News
PANCHSHEEL Share Price: Frequently Asked Questions
What is the current share price of Panchsheel Organics Ltd?
Panchsheel Organics Ltd (PANCHSHEEL) trades at ₹122.75 on NSE and BSE. Market cap ₹180.52 (Cr). Educational data only.
What is the P/E ratio of Panchsheel Organics Ltd?
Panchsheel Organics Ltd has a P/E of 14.68x vs industry average 31.77x.
What is the Bull Run score for Panchsheel Organics Ltd?
Panchsheel Organics Ltd has a Bull Run score of 51.8/100 based on 25+ financial parameters.
Does Panchsheel Organics Ltd pay dividends?
Panchsheel Organics Ltd has a dividend yield of 2.33%. Past dividends don't guarantee future payments.
What is the ROE of Panchsheel Organics Ltd?
Panchsheel Organics Ltd has ROE of 10.65%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Panchsheel Organics Ltd?
Panchsheel Organics Ltd has debt-to-equity of 0.03.
Is Panchsheel Organics Ltd a good investment?
Bull Run gives Panchsheel Organics Ltd a score of 51.8/100. This is not investment advice — consult a SEBI-registered advisor.